• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

    5.905 -0.135 (-2.24%)
    Streaming Delayed Price Updated: 2:30 PM EDT, Aug 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 626,221
    Open 5.990
    Bid (Size) 5.900 (800)
    Ask (Size) 5.910 (1,000)
    Prev. Close 6.040
    Today's Range 5.880 - 6.035
    52wk Range 4.000 - 7.650
    Shares Outstanding 54,191,361
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Abeona (ABEO) Q2 2026 Earnings Call Transcript ↗
    ZEVASKYN revenue surged 31% to $11.4 million as treatment network expanded. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Abeona Therapeutics Q2 2026 Earnings Call Transcript ↗
    Abeona Therapeutics (NASDAQ:ABEO) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For... 
    Via Benzinga
    Topics Earnings

    Performance

    YTD
    +11.2%
    +11.2%
    1 Month
    -1.9%
    -1.9%
    3 Month
    +2.2%
    +2.2%
    6 Month
    +13.6%
    +13.6%
    1 Year
    -14.4%
    -14.4%

    More News

    Read More
    News headline image
    Abeona Therapeutics Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics (NASDAQ:ABEO) Reports First Commercial Revenue and Bolstered Balance Sheet in 2025 ↗
    Via Chartmill
    News headline image
    Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona (ABEO) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Abeona Therapeutics Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Abeona Reports Strong Q1 Revenue, Expands Treatment Center Network ↗
    Via Benzinga
    News headline image
    Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces Date of First Quarter Financial Results
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona (ABEO) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch
    From Abeona Therapeutics Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Abeona Therapeutics Inc. - Common Stock publicly traded?
    Yes, Abeona Therapeutics Inc. - Common Stock is publicly traded.
    What exchange does Abeona Therapeutics Inc. - Common Stock trade on?
    Abeona Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Abeona Therapeutics Inc. - Common Stock?
    The ticker symbol for Abeona Therapeutics Inc. - Common Stock is ABEO on the Nasdaq Stock Market
    What is the current price of Abeona Therapeutics Inc. - Common Stock?
    The current price of Abeona Therapeutics Inc. - Common Stock is 5.905
    When was Abeona Therapeutics Inc. - Common Stock last traded?
    The last trade of Abeona Therapeutics Inc. - Common Stock was at 08/28/26 02:30 PM ET
    What is the market capitalization of Abeona Therapeutics Inc. - Common Stock?
    The market capitalization of Abeona Therapeutics Inc. - Common Stock is 319.98M
    How many shares of Abeona Therapeutics Inc. - Common Stock are outstanding?
    Abeona Therapeutics Inc. - Common Stock has 320M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.